v3.26.1
Statements of Consolidated Income (Loss) - USD ($)
$ in Millions
12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Apr. 30, 2024
Income Statement [Abstract]      
Net sales $ 9,050.9 $ 8,726.1 $ 8,178.7
Cost of products sold [1] 6,016.4 5,341.4 5,063.3
Gross Profit 3,034.5 3,384.7 3,115.4
Selling, distribution, and administrative expenses 1,496.6 1,529.0 1,446.2
Amortization 210.6 219.3 191.1
Goodwill impairment charges 507.5 [2] 1,661.6 [2] 0.0
Other intangible assets impairment charges 454.2 320.9 0.0
Other special project costs [1],[3] 21.1 35.8 130.2
Loss (gain) on divestitures – net 0.0 310.1 12.9
Other operating expense (income) – net (15.7) (18.1) 29.2
Operating Income (Loss) 360.2 (673.9) 1,305.8
Interest expense – net (381.2) (388.7) (264.3)
Other debt gains (charges) – net [1] 0.0 30.2 [3] (19.5)
Other income (expense) – net [3] (41.4) (14.4) (25.6)
Income (Loss) Before Income Taxes (62.4) (1,046.8) 996.4
Income tax expense 76.3 184.0 252.4
Net Income (Loss) $ (138.7) $ (1,230.8) $ 744.0
Earnings per common share:      
Net Income (Loss) (in dollars per share) $ (1.30) $ (11.57) $ 7.14
Net Income (Loss) - Assuming Dilution (in dollars per share) $ (1.30) $ (11.57) $ 7.13
[1] Includes special project costs related to certain divestiture, acquisition, integration, and restructuring activities. For more information, see Note 4: Special Project Costs, Note 5: Reportable Segments, and Note 8: Debt and Financing Arrangements.
[2] Accumulated goodwill impairment charges of $2,412.0 have been recognized as of April 30, 2026.
[3] Includes special project costs related to certain divestiture, acquisition, integration, and restructuring activities. For more information, see Note 4: Special Project Costs and Note 8: Debt and Financing Arrangements.